Efficacy and Safety of an Intravenous Monoclonal Anti-HBs in Chronic Hepatitis B Patients

Liver International - United Kingdom
doi 10.1034/j.1600-0676.2001.021003207.x
Full Text
Abstract

Available in full text

Categories
Hepatology
Date
Authors
Publisher

Wiley

Related search

Development of Anti-Hepatitis B Surface (HBs) Antibodies After HBs Antigen Loss in HIV-hepatitis B Virus Co-Infected Patients

Journal of Clinical Virology
VirologyInfectious Diseases
2017English

Duration of HBs Antigenemia in Patients With Acute Hepatitis B

Acta Hepatologica Japonica
Hepatology
2010English

Comparison of Renal Safety and Efficacy of Telbivudine, Entecavir and Tenofovir Treatment in Chronic Hepatitis B Patients: Real World Experience

Clinical Microbiology and Infection
MedicineInfectious DiseasesMicrobiology
2016English

Safety and Efficacy of Oral HD-03/ES Given for Six Months in Patients With Chronic Hepatitis B Virus Infection

World Journal of Gastroenterology
MedicineGastroenterology
2007English

Efficacy and Safety of Peginterferon Alfa-2a (40KD) in Children With Chronic Hepatitis B: The PEG-B-ACTIVE Study

Hepatology
MedicineHepatology
2018English

Efficacy and Safety of Tenofovir Disoproxil Fumarate in Asian-Americans With Chronic Hepatitis B in Community Settings

PLoS ONE
Multidisciplinary
2014English

Is Occult Hepatitis B Virus Infection With Detectable Anti-HBs Infectious or Not?

Middle East Journal of Digestive Diseases
HepatologyGastroenterology
2016English

Safety and Efficacy of Ofatumumab, a Fully Human Monoclonal Anti-Cd20 Antibody, in Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia: A Phase 1-2 Study

Blood
BiochemistryImmunologyCell BiologyHematology
2008English

Review Article: Long-Term Safety of Oral Anti-Viral Treatment for Chronic Hepatitis B

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy